Ticker Details
Insmed, Inc. Insmed Inc is a global biotechnology company. It is focused on developing novel therapies that focus primarily on lung diseases.
IPO Date:	June 1, 2000
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$35.17B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.47 | 2.81%
Avg Daily Range (30 D):	$3.62 | 2.25%
Avg Daily Range (90 D):	$3.22 | 1.85%

Institutional Daily Volume
Avg Daily Volume:	.68M
Avg Daily Volume (30 D):	2.14M
Avg Daily Volume (90 D):	2.12M

Trade Size
Avg Trade Size (Sh.):	100
Avg Trade Size (Sh.) (30 D):	53
Avg Trade Size (Sh.) (90 D):	53

Institutional Trades
Total Institutional Trades:	9,531
Avg Institutional Trade:	$4.86M
Avg Institutional Trade (30 D):	$14.15M
Avg Institutional Trade (90 D):	$20.92M
Avg Institutional Trade Volume:	.09M
Avg Institutional Trades (Per Day):	3

Market Closing Trades
Avg Closing Trade:	$11.19M
Avg Closing Trade (30 D):	$62.46M
Avg Closing Trade (90 D):	$103.28M
Avg Closing Volume:	184.95K

News

Jan 6, 2026 @ 10:12 PM Stock Market Today, Jan. 6: Alumis Shares Surge on... Source: Howard Smith

Dec 21, 2025 @ 3:01 PM Nike, Insmed, And Arm Are Among Top 10 Large Cap L... Source: Nabaparna Bhattacharya

Dec 13, 2025 @ 1:00 AM Annual Changes to the Nasdaq-100 Index® Source: Nasdaq

Nov 30, 2025 @ 8:14 AM 30% of Billionaire Stanley Druckenmiller's Portfol... Source: Bram Berkowitz

Sep 8, 2025 @ 5:00 PM DPP1 Inhibitor Market Set to Reach New Heights in ... Source: Delveinsight

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-6.42	$-1.53	$-6.42
Diluted EPS	$-6.42	$-1.53	$-6.42
Revenue	$606.42M	$263.84M	$606.42M
Gross Profit	$483.49M	$219.62M	$483.49M
Net Income / Loss	$-1276.78M	$-328.49M	$-1276.78M
Operating Income / Loss	$-1246.77M	$-319.75M	$-1246.77M
Cost of Revenue	$122.94M	$44.22M	$122.94M
Net Cash Flow	$-44.59M	$175.68M	$-44.59M
PE Ratio

Splits
Mar 03, 2011	1:10
Jul 31, 2000	1:4